Enovix Corporation (NASDAQ:ENVX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Enovix Corporation (NASDAQ:ENVX) have received a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, one has given a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $12.6364.

A number of brokerages have recently commented on ENVX. Benchmark lowered their target price on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. Canaccord Genuity Group lowered their target price on Enovix from $21.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Wells Fargo & Company set a $6.00 target price on Enovix in a research note on Thursday, March 12th. B. Riley Financial cut their price target on Enovix from $17.00 to $10.00 and set a “buy” rating for the company in a research note on Monday, March 2nd. Finally, TD Cowen restated a “buy” rating on shares of Enovix in a research note on Thursday, May 14th.

Hedge Funds Weigh In On Enovix

Several institutional investors and hedge funds have recently modified their holdings of ENVX. Caitlin John LLC acquired a new stake in Enovix in the 3rd quarter worth about $27,000. Parallel Advisors LLC boosted its holdings in Enovix by 51.9% in the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after buying an additional 1,342 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in Enovix in the 4th quarter worth about $30,000. CWM LLC boosted its holdings in Enovix by 95.4% in the 4th quarter. CWM LLC now owns 6,081 shares of the company’s stock worth $44,000 after buying an additional 2,969 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new stake in Enovix in the 3rd quarter worth about $80,000. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Enovix Stock Performance

Shares of ENVX opened at $6.66 on Wednesday. The stock has a 50-day moving average of $6.67 and a two-hundred day moving average of $6.75. Enovix has a one year low of $4.61 and a one year high of $16.49. The company has a debt-to-equity ratio of 2.14, a quick ratio of 10.65 and a current ratio of 10.97. The stock has a market cap of $1.45 billion, a P/E ratio of -8.02 and a beta of 2.27.

Enovix (NASDAQ:ENVX) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The business had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.95 million. During the same quarter last year, the business posted ($0.15) EPS. The company’s revenue was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. As a group, research analysts predict that Enovix will post -0.79 EPS for the current year.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.